Edit
Akari Therapeutics
https://www.akaritx.com/?portfolioCats=34,23,29,35,22,24,30,25,28,31#new_tabWe develop life-transforming treatments for autoinflammatory & orphan diseases involving the complement (C5) and leukotriene (LTB4) pathways.
Investors 2
| Date | Name | Website |
| 07.08.2021 | New Enterp... | nea.com |
| - | Vivo Capit... | vivocapita... |
Mentions in press and media 8
| Date | Title | Description | Category | Author | Source |
| 30.03.2023 | Akari Ther... | - | - | - | globenewsw... |
| 12.09.2022 | Akari Ther... | NEW YORK and LONDON, Sept. 12,... | - | - | globenewsw... |
| 04.01.2022 | Akari Ther... | Akari Therapeutics, Plc Announ... | - | - | marketscre... |
| 30.12.2021 | Akari Ther... | NEW YORK and LONDON, Dec. 30, ... | - | - | globenewsw... |
| 30.12.2021 | Akari Ther... | NEW YORK and LONDON, Dec. 30, ... | - | - | marketscre... |
| 22.09.2021 | Akari Ther... | ARREST-BP: A Randomised Placeb... | - | - | marketscre... |
| 29.12.2016 | Why the co... | Humans also have an innate imm... | - | - | medcitynew... |
| - | Why the co... | When drug development and the ... | - | - | medcitynew... |